Head and Neck Cancer: Epidemiology, Prevention, Treatment, and Quality of Life
Deadline for manuscript submissions: 30 September 2024 | Viewed by 3228
2. Lady-Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC H3T 1E2, Canada
Interests: oncology; cancer; quality of life; advanced cancer; head and neck cancer; sociobehavioural determinants of health; prevention
Special Issues, Collections and Topics in MDPI journals
Cancers of the head and neck are the seventh most common cancers worldwide, with over 600,000 new cases annually. They represent different cancer sites including the oral cavity (lips, buccal mucosa, anterior tongue, hard palate, floor of mouth and retromolar trigone), nasopharynx, oropharynx (tonsils, base of tongue, soft palate, uvula, and posterior pharyngeal wall), hypopharynx, and larynx. Head and neck cancers are etiologically linked to the human papilloma virus (HPV) for oropharyngeal cancer and to health behaviors such as smoking and alcohol for non-HPV squamous cell carcinomas; the latter is known to be patterned with social disparities. Head and neck cancers carry an important burden of disease and treatments, with rehabilitation a mainstay as patients often experience disfigurement and dysfunction (e.g., eating, speech, breathing, mobility, distress). Treatments comprise a combination of surgery, radiation therapy, chemotherapy, and/or targeted therapies, with an attention to preserving function and quality of life. This Special Issue is designed to feature research on the epidemiology, prevention, treatment, and quality of life of head and neck cancers. We invite authors to contribute to this issue, which will allow more visibility to a population that is often under-served and -researched.
Dr. Melissa Henry
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- head and neck cancer
- quality of life